CORT has been in the news 500% more than usual
Feb 24, 2026, 11:32 AM
-3.71%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
CORT has been in the news recently: Robbins Geller filed a lawsuit against Corcept Therapeutics, alleging that the company concealed FDA concerns, which contributed to a share price drop of over 50% between October 31, 2024, and December 30, 2025. Additionally, Corcept Therapeutics is set to report its quarterly earnings on February 24, 2026, which investors are advised to closely monitor.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.